Fig. 1From: Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trialMONOD ANRS 12206 Trial profile in Abidjan, Côte d’Ivoire, and Ouagadougou, Burkina Faso, 2011–2015. ART antiretroviral therapy, EFV efavirenz-based ART, LPV lopinavir-boosted-based ARTBack to article page